Abstract:Authentication of species is crucial for ensuring the safety and efficacy of herbal medicines. The fruits of Schisandra chinensis and S. sphenanthera have been used for the same traditional Chinese drug, Wuweizi, but are found to be quite different according to their constituents, pharmacological effects, and qualities. These two fruits have been recorded as Schisandrae Chinensis Fructus (Wuweizi) and Schisandrae Sphenantherae Fructus (Nan-wuweizi), respectively, by Chinese Pharmacopoeia, 2000 edition. However, Nan-wuweizi is often found to be taken as Wuweizi in some Chinese patent drugs intentionally or by mistake because of its lower price and similar characteristics to Wuweizi. In this study, the selection and validation of special chemical markers for the identification of Schisandra species were established by HPLC-DAD-MS profiling analysis. Simple TLC and HPLC methods were proposed for the accurate determination of Nan-wuweizi from Wuweizi in Chinese patent medicines, using schisandrin and anwulignan as the identifying markers for Wuweizi and Nan-wuweizi, respectively. Through the establishment of a statistical model, adulterated or misused ratios of Nan-wuweizi in Wuweizi (w/w), as well as in Fenghan Kesou pills, can be determined. The limit of detection of Nan-wuweizi in a mixture (w/w) using both TLC and HPLC methods is 5% (mixed crude drugs of 50mg and 5g in a 1000g prescribed amount). The constructed statistical model relating the HPLC peak area ratio (anwulignan/schisandrin) and adulteration ratio is suitable for mixed crude drugs and Fenghan Kesou pills, and the two fitting equations have a good correlation (r=0.9979). Furthermore, 36 commercial Chinese patent medicines containing Wuweizi or Nan-wuweizi according to their labels were checked by these methods, and Nan-wuweizi was detected in Renshen Wuweizi Granules and Fenghan Kesou Pills. The ratios of Nan-wuweizi in these mixtures (w/w) were 100:0 for both, which does not comply with the statutory prescription. This study provided a simple and reliable method to prevent the adulteration or misuse of Nan-wuweizi in crude drugs and patent medicines of Wuweizi.

Separation and Structure Identification of the Primary Impurity in γ-Schizandrin

Separation of Catalpol from Rehmannia Glutinosa Libosch by High-Speed Countercurrent Chromatography

Isolation and Structural Elucidation of an Unknown Impurity in Prasugrel by Semi-Preparative Liquid Chromatography.

Preparation Method for Reference Substances of Hyperin and Isorhamnetin-3-O-galactoside

Determination of Schisandrin in Shenan Granules by High Performance Liquid Chromatography

Application of liquid-liquid chromatography as a sample pretreatment method for quantitative analysis of synephrine in <i>Fructus aurantii immaturus</i>

Separation and Characterization of Impurity Pin Azithromycin Product

Separation and Quantification of Four Main Chiral Glucosinolates in Radix Isatidis and Its Granules Using High-Performance Liquid Chromatography/Diode Array Detector Coupled with Circular Dichroism Detection

Analytical Quality by Design Oriented Development of the UPLC Method for Analysing Multiple Pharmaceutical Process Intermediates: A Case Study of Compound Danshen Dripping Pills

Analysis of 'SHUANGDAN' granules by high-performance liquid chromatography-diode array detection-electrospray ionization tandem mass spectrometry.

Comparison of Contents of Deoxyschizandrin and Schisantherrin A in Fructus Sch Isandrae Chinensis

Isolation and structure characterization of related impurities in Sodium Tanshinone IIA Sulfonate by LC/ESI-MS(n) and NMR.

Characterization of Impurities in the Bulk Drug Lisinopril by Liquid Chromatography/ion Trap Spectrometry

Identification of an Unknown Trace-Level Impurity in Bulk Drug of Seroquel by High-Performance Liquid Chromatography Combined with Mass Spectrometry

Characterization of eight unknown impurities and analysis of their source in xinfujunsu and injection by liquid chromatography coupled with ion trap/time-of-flight mass spectrometry

Isolation, structural characterization and quality control strategy of an unknown process-related impurity in sugammadex sodium

Preparation and Identification of Scutellarein by HPLC with an Enzymolysis Reaction

Characterization of a novel trace-level impurity in lisinopril using multi-stage mass spectrometry.

Identification and Quality Control Strategy of Impurities in Zhengqing Fengtongning Injection

Characterization of the Trace-Level Impurities in the Bulk Drug Citalopram by High-Performance Liquid Chromatography/Tandem Multistage Mass Spectrometry

Authentication of Schisandra chinensis and Schisandra sphenanthera in Chinese patent medicines.